NCT07483216

Brief Summary

Fibromyalgia is a chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and functional impairment, which significantly affects quality of life. Physical exercise is considered one of the most effective non-pharmacological interventions for the management of this condition; however, uncertainty remains regarding the most appropriate type, intensity, and frequency of exercise for different patient profiles. The aim of this study is to analyze the effects of a microdoses isokinetic exercise program on physical condition, perceived pain, inflammatory profile and quality of life in women diagnosed with fibromyalgia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Apr 2026Jul 2026

First Submitted

Initial submission to the registry

March 11, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 19, 2026

Completed
13 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

April 16, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

March 11, 2026

Last Update Submit

April 13, 2026

Conditions

Keywords

FibromyalgiaExerciseIsokineticMicrodosingPainNon-Pharmacological treatment

Outcome Measures

Primary Outcomes (5)

  • Peak torque

    The change in the peak torque (in Nm) will be assessed in the concentric part of a knee extension exercise (1x5) at 60º/s using the Biodex System 4.

    Baseline, up to study completion (8 weeks); week 9

  • Peak torque

    The change in the peak torque (in Nm) will be assessed in the eccentric part of a knee extension exercise (1x5) at 60º/s using the Biodex System 4.

    Baseline, up to study completion (8 weeks); week 9

  • Agonist-antagonist ratio

    The change in the agonist-antagonist ratio (%) of the knee extension exercise will be assessed using the Biodex System 4.

    Baseline, up to study completion (8 weeks); week 9

  • Total work

    The change in the total work (in J) of the knee extension exercise will be assessed using the Biodex System 4.

    Baseline, up to study completion (8 weeks); week 9.

  • Height

    The change in the height will be assessed by centimeters (cm).

    Baseline, week 9

Secondary Outcomes (29)

  • Muscle electrical activity (amplitude)

    Baseline, week 9

  • Muscle electrical activity (frequency)

    Baseline, week 9

  • Muscle electrical activity (amplitude)

    Baseline, week 9

  • Muscle electrical activity (frequency)

    Baseline, week 9

  • Weight

    Baseline, week 9

  • +24 more secondary outcomes

Study Arms (2)

Exercise

EXPERIMENTAL

An isokinetic exercise program of microdosing will be conducted over 8 weeks, with a frequency of three sessions per week, each lasting 20-25 minutes. Participants will also receive information on healthy lifestyle habits.

Other: Exercise

Control group

NO INTERVENTION

Participants assigned to the control group will continue with their usual treatment and will receive general recommendations for healthy lifestyle.

Interventions

Participants assigned to the experimental group will perform the sessions under supervision. Each session will begin with a warm-up consisting of joint mobility exercises and 5 minutes of low-intensity cycling. This will be followed by the main exercise component, which will consist of one set of five repetitions of knee extension exercise. During the initial sessions, the exercise will be performed at 60°/s, with a gradual and controlled progression up to a maximum of eight repetitions. To finish, participants will complete 5 minutes of stretching and controlled breathing.

Exercise

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged ≥ 18 years diagnosed with fibromyalgia according to current clinical criteria.
  • Clinical and pharmacological stability during the weeks prior to participation in the study.
  • Ability to perform supervised exercise and to complete the assessments.
  • Written informed consent.

You may not qualify if:

  • Cardiovascular, neurologic, musculoskeletal or systemic pathology that contraindicate the performance of exercise.
  • Significant change in pharmacological treatment during the period immediately preceding the study.
  • Any condition that, in clinical judgement, prevents them from following the protocol safely.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Miguel de Cervantes European University

Valladolid, Valladolid, 47012, Spain

RECRUITING

Related Publications (8)

  • Afonso J, Nakamura FY, Baptista I, Rendeiro-Pinho G, Brito J, Figueiredo P. Microdosing: Old Wine in a New Bottle? Current State of Affairs and Future Avenues. Int J Sports Physiol Perform. 2022 Oct 6;17(11):1649-1652. doi: 10.1123/ijspp.2022-0291. Print 2022 Nov 1.

    PMID: 36202386BACKGROUND
  • Tavares LF, Germano Maciel D, Pereira Barros da Silva TY, Brito Vieira WH. Comparison of functional and isokinetic performance between healthy women and women with fibromyalgia. J Bodyw Mov Ther. 2020 Jan;24(1):248-252. doi: 10.1016/j.jbmt.2019.05.024. Epub 2019 May 23.

    PMID: 31987552BACKGROUND
  • Voss AC, Chambers TL, Gries KJ, Jemiolo B, Raue U, Minchev K, Begue G, Lee GA, Trappe TA, Trappe SW. Exercise microdosing for skeletal muscle health applications to spaceflight. J Appl Physiol (1985). 2024 May 1;136(5):1040-1052. doi: 10.1152/japplphysiol.00491.2023. Epub 2024 Jan 11.

    PMID: 38205550BACKGROUND
  • Larsson A, Palstam A, Lofgren M, Ernberg M, Bjersing J, Bileviciute-Ljungar I, Gerdle B, Kosek E, Mannerkorpi K. Resistance exercise improves muscle strength, health status and pain intensity in fibromyalgia--a randomized controlled trial. Arthritis Res Ther. 2015 Jun 18;17(1):161. doi: 10.1186/s13075-015-0679-1.

    PMID: 26084281BACKGROUND
  • Albuquerque MLL, Monteiro D, Marinho DA, Vilarino GT, Andrade A, Neiva HP. Effects of different protocols of physical exercise on fibromyalgia syndrome treatment: systematic review and meta-analysis of randomized controlled trials. Rheumatol Int. 2022 Nov;42(11):1893-1908. doi: 10.1007/s00296-022-05140-1. Epub 2022 May 23.

    PMID: 35604435BACKGROUND
  • Couto N, Monteiro D, Cid L, Bento T. Effect of different types of exercise in adult subjects with fibromyalgia: a systematic review and meta-analysis of randomised clinical trials. Sci Rep. 2022 Jun 20;12(1):10391. doi: 10.1038/s41598-022-14213-x.

    PMID: 35725780BACKGROUND
  • Estevez-Lopez F, Maestre-Cascales C, Russell D, Alvarez-Gallardo IC, Rodriguez-Ayllon M, Hughes CM, Davison GW, Sanudo B, McVeigh JG. Effectiveness of Exercise on Fatigue and Sleep Quality in Fibromyalgia: A Systematic Review and Meta-analysis of Randomized Trials. Arch Phys Med Rehabil. 2021 Apr;102(4):752-761. doi: 10.1016/j.apmr.2020.06.019. Epub 2020 Jul 25.

    PMID: 32721388BACKGROUND
  • Sosa-Reina MD, Nunez-Nagy S, Gallego-Izquierdo T, Pecos-Martin D, Monserrat J, Alvarez-Mon M. Effectiveness of Therapeutic Exercise in Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Biomed Res Int. 2017;2017:2356346. doi: 10.1155/2017/2356346. Epub 2017 Sep 20.

    PMID: 29291206BACKGROUND

MeSH Terms

Conditions

FibromyalgiaMotor ActivityPain

Interventions

Exercise

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesBehaviorNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Alejandro Santos Lozano, PhD

    Miguel de Cervantes European University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alejandro Santos Lozano, PhD

CONTACT

Sergio Maroto Izquierdo, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The person analyzing the data collected (investigators, statisticians) will not know to which group each person belongs.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Prospective single center randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2026

First Posted

March 19, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

April 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations